Obstructive sleep apnea (OSA) in pregnancy

Eloise Passarella,Nicholas Czuzoj-Shulman,Andrea Spence,Haim Abenhaim
DOI: https://doi.org/10.1016/j.jogc.2020.02.089
2020-05-01
Journal of Obstetrics and Gynaecology Canada
Abstract:Objectives Obstructive sleep apnea (OSA) is associated with numerous medical comorbidities. Our objective is to establish whether OSA increases adverse maternal and neonatal outcomes. Methods We performed a retrospective cohort study using the Healthcare Cost and Utilization Project – National Inpatient Sample from the United States. All pregnant patients with a diagnosis of OSA were identified using International Classification of Disease-9 coding from 2006 to 2015. Trends of OSA over time were calculated, baseline characteristics were compared between pregnancies with and without OSA, and multivariate logistic regression analysis was used to estimate the effect of OSA on maternal and neonatal outcomes. Results Among 7,907,139 births included in our study, 3,115 were to women with OSA, for an overall incidence of 39 per 100,000 births. Rates increased over the 10-year study period, from 10.14 per 100,000 births in 2006 and 78.12 per 100,000 births in 2015(p<0.05). Women with OSA were more likely to have pregnancies complicated by preeclampsia 2.2 (2.0–2.4), eclampsia 4.1 (2.4–7.0), postpartum hemorrhage 1.4 (1.2–1.7), need of blood transfusion 2.2 (1.9–2.7), disseminated intravascular coagulation, 2.4 (1.0–5.4), and venous thromboembolisms, 2.7 (2.1–3.4). Women with OSA were also more likely to develop cardiovascular and respiratory complications. Neonates born to mothers with OSA were more likely to be premature, 1.3 (1.2–1.5), and have congenital malformations, 2.3 (1.7–3.0). Conclusions OSA in pregnancy is associated with and increased risk of adverse maternal and neonatal outcomes. Women with OSA may benefit from management in Tertiary care centres and closer follow-up during pregnancy.
What problem does this paper attempt to address?